Fig. 2From: Elevated levels of plasma inactive stromal cell derived factor-1α predict poor long-term outcomes in diabetic patients following percutaneous coronary interventionCumulative incidences of adverse events in groups divided by median levels of total, active and inactive plasma SDF-1α. a Cumulative incidences of all-cause death and 3P-MACE in patients with high and low plasma total SDF-1α levels. b Cumulative incidences of all-cause death and 3P-MACE in patients with high and low plasma active SDF-1α levels. c Cumulative incidences of all-cause death and 3P-MACE in patients with high and low plasma inactive SDF-1α levelsBack to article page